COLLIER ALAN BRIAN (CEO) purchased 0.0% of their position (700.00 shares) of ENDONOVO THERAPEUTICS, INC. on the open market
Open‑market purchase worth $4.57 — a small addition. The strongest form of insider conviction signal.
P · 5 purchases
Filed: 9/27/2019ACC: 0001645470-19-000050
Officer· CEO
Since Jun 2016
+700.00
Net shares
Net buyer
$4.57
Total acquired
5
Open market trades
5B · 0S
5
Total transactions
700.00 acquired
Non-Derivative Transactions5
Common Stock
Direct
Shares
+100.00
Price / share
$0.01
Trade value
$0.64
% of position
0.0%
9/24/2019
25.33M→25.33M
Common Stock
Direct
Shares
+100.00
Price / share
$0.01
Trade value
$0.62
% of position
0.0%
9/24/2019
25.33M→25.33M
Common Stock
Direct
Shares
+100.00
Price / share
$0.01
Trade value
$0.67
% of position
0.0%
9/25/2019
25.33M→25.33M
Common Stock
Direct
Shares
+200.00
Price / share
$0.01
Trade value
$1.36
% of position
0.0%
9/25/2019
25.33M→25.33M
Common Stock
Direct
Shares
+200.00
Price / share
$0.01
Trade value
$1.28
% of position
0.0%
9/25/2019
25.33M→25.33M
Total
Net shares
+700.00
Net value
$4.57
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/24/2019 | P · Purchase | +100.00 | $0.01 | $0.64 | 0.0% | 25.33M | 25.33M |
| Common Stock Direct | 9/24/2019 | P · Purchase | +100.00 | $0.01 | $0.62 | 0.0% | 25.33M | 25.33M |
| Common Stock Direct | 9/25/2019 | P · Purchase | +100.00 | $0.01 | $0.67 | 0.0% | 25.33M | 25.33M |
| Common Stock Direct | 9/25/2019 | P · Purchase | +200.00 | $0.01 | $1.36 | 0.0% | 25.33M | 25.33M |
| Common Stock Direct | 9/25/2019 | P · Purchase | +200.00 | $0.01 | $1.28 | 0.0% | 25.33M | 25.33M |
| Total | +700.00 | $4.57 | ||||||
Derivative Transactions0
No derivative transactions reported